GUARDIAN (NCT04884802) Sub-study, Etomidate vs Propofol
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
Some patients participating in the underlying GUARDIAN trial (NCT04884802) will be
additionally randomized to etomidate vs propofol for anesthetic induction.